Results 201 to 210 of about 3,928,328 (244)
ABSTRACT Background Body composition changes during glucagon‐like peptide‐1 (GLP‐1)‐based therapy remain incompletely characterized, particularly regarding their effects on adiposity, muscle quantity, and muscle quality. We conducted a systematic review and meta‐analysis using a predefined physiological framework to evaluate body composition ...
Maria Luizza Lopes Menezes +6 more
wiley +1 more source
In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia. [PDF]
Welegebrial BG +6 more
europepmc +1 more source
ABSTRACT Aims To evaluate whether a community‐based personalised lifestyle intervention guided by intermittent continuous glucose monitoring (CGM) improves glycaemic and cardiometabolic outcomes in adults with type 2 diabetes. Materials and Methods In this multicentre, open‐label randomised trial, 180 adults with type 2 diabetes and pre‐randomisation ...
Yaqing Liu +6 more
wiley +1 more source
Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes. [PDF]
Teli B +9 more
europepmc +1 more source
ABSTRACT Aims Managing postprandial glycaemic variability is crucial for preventing metabolic diseases. Although the effects of a vegetable‐first meal sequence on blood glucose levels have been well documented, there is limited research on consecutive, repeated meal sequencing for healthy young women.
Minji Choi +9 more
wiley +1 more source
Tariffs and Emergency Medicine in the United States: An Unintended Healthcare Crisis. [PDF]
Ajay Jadav A +5 more
europepmc +1 more source
Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou +5 more
wiley +1 more source
Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]
Taylor H, Rahman N.
europepmc +1 more source
ABSTRACT Aim Analyse the cost‐effectiveness of the Omnipod 5 automated insulin delivery system versus multiple daily injections (MDI) with continuous glucose monitoring for type 1 diabetes among adults in Sweden. Methods Cost‐effectiveness was analysed with the IQVIA Core Diabetes Model (version 10.0) taking the perspective of the payer in Sweden ...
Johan Jendle +5 more
wiley +1 more source
A novel framework for quantifying the clinical impact of substandard and falsified antimicrobials: Application to typhoid fever. [PDF]
Cavany S +11 more
europepmc +1 more source

